On April 18, 2025, Malaysia marked a significant milestone in its healthcare and scientific advancement with a press conference highlighting the MyGenom Project. This national initiative aims to establish a comprehensive genomic reference for the Malaysian population, facilitating early disease detection and the development of personalized treatment strategies.

The event, held at the Malaysia Genome and Vaccine Institute (MGVI), National Institutes of Biotechnology Malaysia (NIBM) in Bangi, was attended by Science, Technology and Innovation Minister Chang Lih Kang, and Health Minister Datuk Seri Dr Dzulkefly Ahmad. Both ministers participated in a symbolic blood sample collection, underscoring their commitment to the project’s objectives.

Launched on August 29, 2024, the MyGenom Project has already enrolled 2,000 participants in its first phase. The initiative is a collaborative effort between the Ministry of Health and the Ministry of Science, Technology and Innovation, with sequencing efforts led by MGVI and the NIBM. The project utilizes the Illumina Novaseq X Plus, Malaysia’s first population-scale genome sequencing machine.

Health Minister Dzulkefly emphasized the project’s potential to revolutionize healthcare in Malaysia by enabling precise, data-driven approaches to disease prevention and treatment. He stated, “This research enables us to identify the origins of diseases and propose preventive measures and early intervention strategies.” 

Minister Chang Lih Kang highlighted the project’s role in ensuring equitable healthcare access across all communities, stating that mapping the country’s genetic diversity is crucial for developing inclusive treatment strategies.

The MyGenom Project represents a significant step towards integrating genomic data into Malaysia’s healthcare system, aiming to enhance disease understanding and improve patient outcomes through personalized medicine.